5 hours Danaher Gears Up to Report Q3 Earnings: What’s in the Cards?Zacks
DHR’s Q3 results are likely to be affected by weakness in the Biotechnology and Life Sciences segment.
XDHR’s Q3 results are likely to be affected by weakness in the Biotechnology and Life Sciences segment.
X